Department of Gastroenterology.
Department of Pathology.
Medicine (Baltimore). 2024 Feb 9;103(6):e37195. doi: 10.1097/MD.0000000000037195.
Amebic colitis has been less prevalent in recent times in China, and the similarity of its symptoms to those of inflammatory bowel disease (IBD) results in the difficulty of early identification and diagnosis.
A 31-year-old male who exhibited intermittent diarrhea and hematochezia was highly suspected as IBD initially. Despite the partial relief of symptoms following the administration of mesalamine, the endoscopic ulcers remained largely unchanged.
Two years after the onset of mesalamine therapy, amebic cysts were detected in stool microscopy and trophozoites were found on the surface of cecal ulcers. The patient was then diagnosed with amebic colitis.
After 2 rounds of standardized metronidazole treatment, amebic colitis remained refractory until diloxanide was administered.
The patient remained asymptomatic, and the mucosa of colon was normal during the annual follow-up.
Individuals newly diagnosed with IBD should undergo essential screening for amebiasis. And the use of steroids should be taken with caution, especially in cases where the effect of mesalamine is limited. For symptomatic intestinal amebiasis, even after the administration of tissue amebicides, the continued use of luminal amebicides is necessary to prevent recurrence.
近年来,中国的阿米巴结肠炎的发病率有所降低,其症状与炎症性肠病(IBD)相似,导致早期识别和诊断较为困难。
一名 31 岁男性,间歇性腹泻和便血,最初高度怀疑为 IBD。尽管给予美沙拉嗪后症状部分缓解,但内镜下溃疡基本无变化。
在开始使用美沙拉嗪治疗 2 年后,粪便显微镜检查发现阿米巴包囊,盲肠溃疡表面发现滋养体。随后诊断为阿米巴结肠炎。
经过 2 轮标准化甲硝唑治疗后,阿米巴结肠炎仍未缓解,直至使用二氯尼特。
患者无症状,每年随访时结肠黏膜正常。
新诊断为 IBD 的患者应进行基本的阿米巴病筛查。并且应谨慎使用类固醇,特别是在美沙拉嗪效果有限的情况下。对于有症状的肠阿米巴病,即使给予组织杀阿米巴药物治疗后,仍需继续使用腔道杀阿米巴药物以预防复发。